2-(trifluoromethyl)-4H-3,1-benzoxazin-4-one
![]() |
- $189 - $750.75
- Product name: 2-(trifluoromethyl)-4H-3,1-benzoxazin-4-one
- CAS: 16062-71-8
- MF: C9H4F3NO2
- MW: 215.13
- EINECS:
- MDL Number:MFCD00175074
- Synonyms:2-(trifluoromethyl)-4H-3,1-benzoxazin-4-one;2-(trifluoromethyl)-3,1-benzoxazin-4-one;2-(trifluoromethyl)-4H-benzo[d][1,3]oxazin-4-one;4H-3,1-Benzoxazin-4-one, 2-(trifluoromethyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 0.5G
- 500mg
- 1G
- ManufacturerAK Scientific
- Product number5132AD
- Product description2-(Trifluoromethyl)-4H-3,1-benzoxazin-4-one
- Packaging500mg
- Price$305
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0042806
- Product description2-(TRIFLUOROMETHYL)-4H-3,1-BENZOXAZIN-4-ONE 95.00%
- Packaging0.5G
- Price$682
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0042806
- Product description2-(TRIFLUOROMETHYL)-4H-3,1-BENZOXAZIN-4-ONE 95.00%
- Packaging1G
- Price$750.75
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number039860
- Product description2-(Trifluoromethyl)-4H-3,1-benzoxazin-4-one
- Packaging500mg
- Price$189
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 5132AD | 2-(Trifluoromethyl)-4H-3,1-benzoxazin-4-one | 500mg | $305 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0042806 | 2-(TRIFLUOROMETHYL)-4H-3,1-BENZOXAZIN-4-ONE 95.00% | 0.5G | $682 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0042806 | 2-(TRIFLUOROMETHYL)-4H-3,1-BENZOXAZIN-4-ONE 95.00% | 1G | $750.75 | 2021-12-16 | Buy |
Matrix Scientific | 039860 | 2-(Trifluoromethyl)-4H-3,1-benzoxazin-4-one | 500mg | $189 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|